Topas Therapeutics

Topas Therapeutics is a biotech company in Hamburg, Germany, founded in 2016. It has raised $110.8M across 4 rounds, most recently a $48.0M Extension Round in July 2021.

Transforming the field of immune tolerance

Headquarters
Hamburg
Employees
11–50
Founded
2016
Total Funding
$110.8M
Last Round
$48.0M Extension RoundJul 2021
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 6 investors for this company. The full record is or through the API.

About

Topas Therapeutics develops therapies designed to establish immune tolerance in autoimmune and immune-mediated diseases. Its proprietary Topas Particle Conjugates platform uses antigen-coupled nanoparticles to target liver sinusoidal endothelial cells, prompt anti-inflammatory immune responses and drive T cells toward tolerance. Its approach seeks targeted, antigen-specific tolerance for patients.

Summary

It lists 11–50 employees. It has raised $110.8M in total across 4 rounds, most recently a $48.0M Extension Round in Jul 2021. Investors include Epidarex Capital, Boehringer Ingelheim Venture Fund and BioMedPartners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundSeries B ExtensionJul 2021
$48.0M

Sign up to see all 4 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Topas Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/topas-therapeutics"><img src="https://indexed.vc/api/badge/company/topas-therapeutics" alt="Topas Therapeutics on Indexed.vc" width="260" height="76" /></a>